Trial NCT03909295

View at ClinicalTrials.gov 
Org. Study IDs: CLCZ696D1301E1

Last trial update was posted on 2021-10-08

MeSH Interventions

Sacubitril and valsartan sodium hydrate drug combination Valsartan

MeSH Conditions

Heart Failure

Other Conditions

Heart Failure With Preserved Ejection Fraction (HFpEF)

Stopping Reasons

This study was terminated early because the primary endpoint of PARAGON-HF was not met.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID